CompletedNCT00501631
Naltrexone injection or placebo after alcohol abstinence
About this title
Read the official source — NCT00501631Medication studyAges 18–65Addiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJuly 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 300
- Sponsor
- Alkermes, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00501631
- Official title
Show the full official title
Efficacy and Safety of VIVITROL® in Adults Completing Inpatient Treatment for Alcohol Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is Alkermes, Inc.
Did this study involve medication?
Yes. The study involved medication, including VIVITROL 380 mg and Placebo for VIVITROL 380 mg.
Who was this study for?
Listed age limits: 18 years to 65 years.
